The diabetic wound is excessively vulnerable to infection because the diabetic wound suggests delayed and incomplete healing techniques. Presently, wounds and ulcers related to diabetes have additionally increased the medical burden. A diabetic wound can impair mobility, lead to amputations, or even death. In recent times, advanced drug delivery systems have emerged as promising approaches for enhancing the efficacy of wound healing treatments in diabetic patients. This review aims to provide an overview of the current advancements in drug delivery systems in managing chronic diabetic wound healing. This review begins by discussing the pathophysiological features of diabetic wounds, including impaired angiogenesis, elevated reactive oxygen species, and compromised immune response. These factors contribute to delayed wound healing and increased susceptibility to infection. The importance of early intervention and effective wound management strategies is emphasized. Various types of advanced drug delivery systems are then explored, including nanoparticles, hydrogels, transferosomes, liposomes, niosomes, dendrimers, and nanosuspension with incorporated bioactive agents and biological macromolecules are also utilized for chronic diabetes wound management. These systems offer advantages such as sustained release of therapeutic agents, improved targeting and penetration, and enhanced wound closure. Additionally, the review highlights the potential of novel approaches such as antibiotics, minerals, vitamins, growth factors gene therapy, and stem cell-based therapy in diabetic wound healing. The outcome of advanced drug delivery systems holds immense potential in managing chronic diabetic wound healing. They offer innovative approaches for delivering therapeutic agents, improving wound closure, and addressing the specific pathophysiological characteristics of diabetic wounds.

Negative pressure wound therapy (NPWT) is a widely used and effective treatment for managing complex wounds. This document discusses how NPWT can be used in wound care in an updated way. The updated scenario on NPWT provides a concise overview of the current state of NPWT and its implications in clinical practice. It highlights recent developments in NPWT, as well as the advancements in this field. As part of NPWT, vacuum-assisted closure is used and negative pressure is applied to the wound bed. It discusses the key components and mechanisms. In addition to improving wound healing, NPWT also reduces infection rates and improves patient comfort, among other benefits. In addition, this document discusses the specific indications and contraindications of NPWT, as well as the types of wounds that can be treated with NPWT, including diabetic foot ulcers, pressure ulcers, and traumatic wounds. The document emphasizes the importance of choosing patients appropriately and assessing wounds to ensure optimal outcomes. In addition, it provides evidence-based guidelines and clinical recommendations on NPWT. In addition to reviewing the latest research findings supporting NPWT in a variety of clinical settings, it also discusses randomized controlled trials and systematic reviews. In addition, it discusses the potential complications and challenges associated with NPWT, including pain, bleeding, and device malfunction. The purpose of this document is to shed light on the role of NPWT in wound care management by providing an updated scenario. NPWT can be incorporated into clinical practice by healthcare professionals if they understand its principles, benefits, indications, and limitations. Healthcare providers can optimize patient outcomes and improve wound healing in diverse patient populations by staying abreast of the latest advancements in NPWT.

This study focuses on the development of luteolin-loaded niosomes aimed at enhancing the therapeutic efficacy and bioavailability of luteolin for wound healing applications. Luteolin, despite its potential, faces significant limitations such as low absorption, poor water solubility, and reduced bioavailability. To overcome these challenges, a sustained-release formulation of luteolin-loaded niosomes was developed for topical application. The formulation was optimized using Design Expert software (Version 11) inBox-Behnken Design (BBD) through response surface methodology. Niosomes were prepared via the thinfilm hydration method, with three factors and two levels used in the optimization process. The niosomal preparationswere evaluated by polydispersity index (PDI), zeta potential, vesicle size, entrapment efficiency (EE), Fouriertransform infrared spectroscopy (FTIR), and in-vitro drug release profile. The optimized luteolin-loaded niosomes showed a vesicle size of 267.2 nm, a PDI of 0.34, a zeta potential of -20.25 mV, and an EE of 78.31%. In-vitro drug release studies established a sustained release of 67.08% over 12 hours. These results demonstrate that the developed luteolin-loaded niosomal formulations have the potential for sustained release, improving the therapeutic efficacy of luteolin in wound healing applications. This formulation shows promise in addressing the bioavailability issues of luteolin and enhancing its effectiveness in wound management.

Hyperglycemia is a metabolic illness characterized by diabetes mellitus. Chronic hyperglycemia can lead to infection, production of more reactive oxygen species, chronic inflammation, and impaired angiogenesis, thus increasing the wound’s healing time. As the diabetic wound healing process is a more complex pathology, the demand to develop a topical application has emerged. This review focuses on the diabetic wound, wound healing, and the factors that influence diabetic wound healing. It also highlights the impact of combination delivery of antibiotics and antioxidants loaded with multifunctional hydrogel on diabetic wound healing. Due to the immense financial strain caused by this pathology, there is a need for other effective novel methods for wound healing. Therefore, multifunctional hydrogels, which are effective and have been used mainly as a carrier system for diabetic wound treatment, have been studied. Hence, the application of antibiotics and antioxidants loaded with multifunctional hydrogel in treating diabetic wounds is reviewed. Hydrogels present a significant theoretical reference for diabetic wound healing.

Polymerase Chain Reaction (PCR) has revolutionized the field of molecular biology since its invention in 1983. The technique has enabled scientists to amplify specific sequences of the genomic DNA for various applications, from basic research to clinical diagnosis. However, like any other experimental protocol, PCR has its limitations and challenges. Troubleshooting and optimization are crucial steps for achieving consistent and reliable results in PCR. This review provides an overview of the history of PCR, highlighting its evolution over the past four decades. The article also discusses common troubleshooting strategies and optimization methods that researchers use to overcome obstacles in PCR experiments. By understanding the principles and techniques of PCR optimization, scientists can design experiments that efficiently amplify specific DNA sequences, minimize non-specific amplification, and improve the overall accuracy and sensitivity of the results.